BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 5096509)

  • 1. Detection of intravascular coagulation.
    Kisker CT; Rush R
    J Clin Invest; 1971 Nov; 50(11):2235-41. PubMed ID: 5096509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for measurement of fibrin monomer with the use of an immune precipitate of fibrinogen.
    Kisker CT; Plummer G; Taylor B; Rush R
    J Lab Clin Med; 1977 Mar; 89(3):653-8. PubMed ID: 839123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated intravascular coagulation (DIC).
    Mammen EF
    Clin Lab Sci; 2000; 13(4):239-45. PubMed ID: 11586511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficiency and limits of laboratory diagnosis of diffuse intravascular blood coagulation processes].
    Heene DL; Lasch HG
    Internist (Berl); 1973 Apr; 14(4):154-9. PubMed ID: 4268495
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.
    Lorand L; Urayama T; De Kiewiet JW; Nossel HL
    J Clin Invest; 1969 Jun; 48(6):1054-64. PubMed ID: 4977030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of the enzyme preparation ancistron-N in the diagnosis of disseminated intravascular coagulation].
    Neĭko EM; Serediuk NN; Fabrika AV
    Vrach Delo; 1990 Apr; (4):57-60. PubMed ID: 2275170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggristin (ristomycin) precipitation test: a new tool for the detection of fibrin monomer and fibrin degradation products.
    Pfliegler G; Vogel G; Boda Z; Zajka G; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):629-35. PubMed ID: 2414192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reliability of tests for fibrinogen (fibrin) degradation products in plasma with thrombin coagulase, reptilase and thrombin clotting time (author's transl)].
    Wenzel E; Holzhüter H; Muschietti F; Angelkort B; Ochs HG; Pusztai-Markos S; Nowak H; Stürner H
    Dtsch Med Wochenschr; 1974 Apr; 99(15):746-56. PubMed ID: 4858105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
    Klingemann HG; Brunswig D; Liehr H
    Z Gastroenterol; 1978 Sep; 16(9):564-73. PubMed ID: 706517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay.
    Wiman B; Rånby M
    Thromb Haemost; 1986 Apr; 55(2):189-93. PubMed ID: 3087001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A simple method for the determination of intravascular clotting and fibrinolysis].
    Latallo ZS; Wegrzynowicz Z; Kopeć M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):32-5. PubMed ID: 4114580
    [No Abstract]   [Full Text] [Related]  

  • 18. The fibrinogen functional turbidimetric assay.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):84-96. PubMed ID: 18160594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive detection of the activation state of blood coagulation in porcine DIC models by a new fibrin immunoassay.
    Spannagl M; Trauner A; Birg A; Frank G; Hoffmann H; Siebeck M; Lill H
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):103-6. PubMed ID: 8457635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.